# The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion

> **NCT05038072** · NA · COMPLETED · sponsor: **Damascus University** · enrollment: 16 (actual)

## Conditions studied

- Macular Edema
- Retinal Vein Occlusion

## Interventions

- **DRUG:** suprachoroidal injection of Triamcinolone Acetonide.

## Key facts

- **NCT ID:** NCT05038072
- **Lead sponsor:** Damascus University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-25
- **Primary completion:** 2020-11-22
- **Final completion:** 2021-02-28
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05038072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05038072, "The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05038072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*